Cargando…

Phytochemicals: Target-Based Therapeutic Strategies for Diabetic Retinopathy

Background: A variety of causative factors are involved in the initiation of diabetic retinopathy (DR). Current antidiabetic therapies are expensive and not easily accessible by the public. Furthermore, the use of multiple synthetic drugs leads to severe side effects, which worsen the diabetic patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Parveen, Amna, Kim, Jin Hyun, Oh, Byeong Gyu, Subedi, Lalita, Khan, Zahra, Kim, Sun Yeou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6100391/
https://www.ncbi.nlm.nih.gov/pubmed/29937497
http://dx.doi.org/10.3390/molecules23071519
_version_ 1783348862703894528
author Parveen, Amna
Kim, Jin Hyun
Oh, Byeong Gyu
Subedi, Lalita
Khan, Zahra
Kim, Sun Yeou
author_facet Parveen, Amna
Kim, Jin Hyun
Oh, Byeong Gyu
Subedi, Lalita
Khan, Zahra
Kim, Sun Yeou
author_sort Parveen, Amna
collection PubMed
description Background: A variety of causative factors are involved in the initiation of diabetic retinopathy (DR). Current antidiabetic therapies are expensive and not easily accessible by the public. Furthermore, the use of multiple synthetic drugs leads to severe side effects, which worsen the diabetic patient’s condition. Medicinal plants and their derived phytochemicals are considered safe and effective treatment and their consumption can reduce the DR risk. In this article, we discuss a variety of medicinal plants, and their noteworthy bio-active constituents, that will be utilized as target based therapeutic strategies for DR. Methods: A broad-spectrum study was conducted using published English works in various electronic databases including Science Direct, PubMed, Scopus, and Google Scholar. Results: Targeting the multiple pathological factors including ROS, AGEs formation, hexosamine flux, PARP, PKC, and MAPK activation through variety of bioactive constituents in medicinal plants, diabetes progression can be delayed with improved loss of vision. Conclusions: Data reveals that traditional herbs and their prominent bioactive components control and normalize pathological cellular factors involved in DR progression. Therefore, studies should be carried out to explore the protective retinopathy effects of medicinal plants using experimental animal and humans models.
format Online
Article
Text
id pubmed-6100391
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-61003912018-11-13 Phytochemicals: Target-Based Therapeutic Strategies for Diabetic Retinopathy Parveen, Amna Kim, Jin Hyun Oh, Byeong Gyu Subedi, Lalita Khan, Zahra Kim, Sun Yeou Molecules Review Background: A variety of causative factors are involved in the initiation of diabetic retinopathy (DR). Current antidiabetic therapies are expensive and not easily accessible by the public. Furthermore, the use of multiple synthetic drugs leads to severe side effects, which worsen the diabetic patient’s condition. Medicinal plants and their derived phytochemicals are considered safe and effective treatment and their consumption can reduce the DR risk. In this article, we discuss a variety of medicinal plants, and their noteworthy bio-active constituents, that will be utilized as target based therapeutic strategies for DR. Methods: A broad-spectrum study was conducted using published English works in various electronic databases including Science Direct, PubMed, Scopus, and Google Scholar. Results: Targeting the multiple pathological factors including ROS, AGEs formation, hexosamine flux, PARP, PKC, and MAPK activation through variety of bioactive constituents in medicinal plants, diabetes progression can be delayed with improved loss of vision. Conclusions: Data reveals that traditional herbs and their prominent bioactive components control and normalize pathological cellular factors involved in DR progression. Therefore, studies should be carried out to explore the protective retinopathy effects of medicinal plants using experimental animal and humans models. MDPI 2018-06-23 /pmc/articles/PMC6100391/ /pubmed/29937497 http://dx.doi.org/10.3390/molecules23071519 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Parveen, Amna
Kim, Jin Hyun
Oh, Byeong Gyu
Subedi, Lalita
Khan, Zahra
Kim, Sun Yeou
Phytochemicals: Target-Based Therapeutic Strategies for Diabetic Retinopathy
title Phytochemicals: Target-Based Therapeutic Strategies for Diabetic Retinopathy
title_full Phytochemicals: Target-Based Therapeutic Strategies for Diabetic Retinopathy
title_fullStr Phytochemicals: Target-Based Therapeutic Strategies for Diabetic Retinopathy
title_full_unstemmed Phytochemicals: Target-Based Therapeutic Strategies for Diabetic Retinopathy
title_short Phytochemicals: Target-Based Therapeutic Strategies for Diabetic Retinopathy
title_sort phytochemicals: target-based therapeutic strategies for diabetic retinopathy
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6100391/
https://www.ncbi.nlm.nih.gov/pubmed/29937497
http://dx.doi.org/10.3390/molecules23071519
work_keys_str_mv AT parveenamna phytochemicalstargetbasedtherapeuticstrategiesfordiabeticretinopathy
AT kimjinhyun phytochemicalstargetbasedtherapeuticstrategiesfordiabeticretinopathy
AT ohbyeonggyu phytochemicalstargetbasedtherapeuticstrategiesfordiabeticretinopathy
AT subedilalita phytochemicalstargetbasedtherapeuticstrategiesfordiabeticretinopathy
AT khanzahra phytochemicalstargetbasedtherapeuticstrategiesfordiabeticretinopathy
AT kimsunyeou phytochemicalstargetbasedtherapeuticstrategiesfordiabeticretinopathy